Routine cardiac evaluation in patients with early-stage breast cancer before adjuvant chemotherapy

Clinical Breast Cancer

Volumn 12, Issue 1, 2012, Pages 4-9

  Jeyakumar, Alwin ^a   Dipenta, Jillian ^b   Snow, Stephanie ^a   Rayson, Daniel ^a   Thompson, Kara ^a   Theriault, Chris ^a   Younis, Tallal ^a  

^a QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Adjuvant therapy; Anthracycline; Breast cancer; Multigated acquisition scan; Women

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; TAXANE DERIVATIVE; TRASTUZUMAB;

ADULT; AGED; ARTICLE; BREAST CANCER; CANADA; CANCER ADJUVANT THERAPY; CANCER STAGING; CARDIOVASCULAR RISK; EARLY CANCER; ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART SCINTISCANNING; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MULTIGATED ACQUISITION SCAN; PATIENT ASSESSMENT; RETROSPECTIVE STUDY; SMOKING;

EID: 84856058401     PISSN: 15268209     EISSN: 19380666     Source Type: Journal    
DOI: 10.1016/j.clbc.2011.07.006     Document Type: Article

References (14)

1. M. Trudeau, F. Charbonneau, K. Gelmon Selection of adjuvant chemotherapy for treatment of node-positive breast cancer Lancet Oncol 6 2005 886 898 (Pubitemid 41614801)
2. Anthracycline-induced cardiotoxicity National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology-. National Comprehensive Cancer Network [Web site] http://www.nccn.org/professionals/physician-gls/f- guidelines.asp#site Accessed: April 2011.
3. K. Shan, A.M. Lincoff, J.B. Young Anthracycline-induced cardiotoxicity Ann Intern Med 125 1996 47 58
4. K.Singal Pawan, N. Iliskovic Doxorubicin-induced cardiomyopathy N Engl J Med 339 1998 900 905 (Pubitemid 28446849)
5. M. Ryberg, D. Nielsen, T. Skovsgaard Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer J Clin Oncol 16 1998 3502 3508 (Pubitemid 28506760)
6. D.D. Von Hoff, M. Rozencweig, M. Layard Daunomycin-induced cardiotoxicity in children and adults A review of 110 cases Am J Med 62 1977 200 208 (Pubitemid 8042834)
7. S.M. Swain, F.S. Whaley, M.S. Ewer Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials Cancer 97 2003 2869 2879 (Pubitemid 36605157)
8. J. Yahalom, C.S. Portlock Cardiac toxicity DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology 8th edition 2008 Lippincott Williams & Wilkins USA 2679 2687
9. M.T. Meinardi, W.T. van der Graaf, D.J. van Veldhuisen Detection of anthracycline-induced cardiotoxicity Cancer Treat Rev 25 1999 237 247 (Pubitemid 29417681)
10. W.H. Hall, R. Ramachandran, S. Narayan An electronic application for rapidly calculating Charlson comorbidity score BMC Cancer 4 2004 94
11. P. Rastogi, J. Jeong, C.E. Geyer Five year update of cardiac dysfunction on NSABP B-31, a randomized trial of sequential doxorubicin/cyclophosphamide (AC) > paclitaxel (T) vs. AC > T with trastuzumab (H) 2007 ASCO Annual Meeting Proceedings (Post-Meeting Edition) J Clin Oncol 25 suppl 2007 LBA513
12. M.S. Sabel, E.G. Levine, T. Hurd Is MUGA scan necessary in patients with low-risk breast cancer before doxorubicin-based adjuvant therapy? Am J Clin Oncol 24 2001 425 428 (Pubitemid 32730747)
13. A.L. Conrad, V.L. McHugh, J.D. Gundrum Utility of routine cardiac ejection fraction (EF) measurement prior to anthracycline-based chemotherapy (ABC) in patients with diffuse large b-cell lymphoma (DLBCL) 2010 ASCO Annual Meeting Proceedings (Post-Meeting Edition) J Clin Oncol 28 suppl 2010 6101
14. N.V. Karanth, A. Roy, M. Joseph Utility of pre-chemotherapy echocardiographical assessment of cardiac abnormalities 2010 ASCO Annual Meeting Proceedings (Post-Meeting Edition) J Clin Oncol 28 suppl 2010 9049